Literature DB >> 12684160

Myocardial tissue troponins T and I. An immunohistochemical study in experimental models of myocardial ischemia.

Michael C Fishbein1, Tiffany Wang, Maria Matijasevic, Longsheng Hong, Fred S Apple.   

Abstract

BACKGROUND: Cardiac troponins T (cTnT) and I (cTnI) are proven diagnostic and risk stratification biomarkers in patients with acute coronary syndromes. To date, no immunohistochemical studies have been performed which allow visualization of the time course and pattern of myocardial troponin egress from the myocardium during the early evolution of ischemic injury in experimental systems.
METHODS: We studied archival formalin-fixed, paraffin-embedded myocardium from 50 experimental animals (dogs, pigs and rats) that had undergone permanent coronary occlusion (n = 34) for 0.5-6 h or occlusion of 0.75-6 h followed by reperfusion (n = 16). Histologic sections that included ischemic and nonischemic myocardium were studied by immunohistochemistry with three different antibodies to human cTnI and one to cTnT, using a standard avidin-biotin-peroxidase system.
RESULTS: All antibodies detected cTnT or cTnI in normal myocardium and its loss from necrotic myocardium, in some cases as early as 30 min after coronary occlusion, before histologic evidence of necrosis was present. Loss was nonuniform, being greater at the periphery of the infarcts then at their central regions. Usually, loss of cTnT appeared greater than loss of cTnI. With reperfusion, findings were similar to those after permanent occlusion, except that there was a greater contrast between loss at the periphery compared to the loss in the central region. Considerable residual staining persisted for hours after occlusion, indicating delayed release over time, concordant with sustained serum elevations in patients with acute myocardial infarction. No loss of staining was observed in nonnecrotic myocardium.
CONCLUSIONS: Immunohistochemical staining using antibodies to human cTnT and cTnI can be used to visualize cardiac troponins and document their loss in histologic sections of myocardium in different animal species. Loss of cTnT and cTnI occurs very early following ischemic injury and may precede histologic evidence of necrosis, but does not occur in myocardium that is not necrotic. Immunohistochemical staining of hearts for cTnT and cTnI can assist in the often difficult recognition of myocardial necrosis at autopsy, in patients suspected of dying from acute myocardial ischemia. Copyright 2003 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684160     DOI: 10.1016/s1054-8807(02)00188-6

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  38 in total

Review 1.  An update on cardiac troponins as circulating biomarkers in heart failure.

Authors:  Serge Masson; Roberto Latini; Inder S Anand
Journal:  Curr Heart Fail Rep       Date:  2010-03

2.  Early markers for myocardial ischemia and sudden cardiac death.

Authors:  Sara Sabatasso; Patrice Mangin; Tony Fracasso; Milena Moretti; Mylène Docquier; Valentin Djonov
Journal:  Int J Legal Med       Date:  2016-07-08       Impact factor: 2.686

3.  Cardiospecificity of the 3rd generation cardiac troponin T assay during and after a 216 km ultra-endurance marathon run in Death Valley.

Authors:  H J Roth; R M Leithäuser; H Doppelmayr; M Doppelmayr; H Finkernagel; S P von Duvillard; S Korff; H A Katus; Evangelos Giannitsis; R Beneke
Journal:  Clin Res Cardiol       Date:  2007-04-26       Impact factor: 5.460

4.  Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35.

Authors:  Marc S Sabatine; David A Morrow; James A de Lemos; Petr Jarolim; Eugene Braunwald
Journal:  Eur Heart J       Date:  2008-11-08       Impact factor: 29.983

5.  Biological variation of high sensitive Troponin T in stable heart failure patients with ischemic or dilated cardiomyopathy.

Authors:  Lutz Frankenstein; Andrew Remppis; Evangelos Giannitis; Joerdis Frankenstein; Georg Hess; Dietmar Zdunek; Andreas Doesch; Christian Zugck; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2011-02-17       Impact factor: 5.460

Review 6.  Immunohistochemical detection of early myocardial infarction: a systematic review.

Authors:  Cristina Mondello; Luigi Cardia; Elvira Ventura-Spagnolo
Journal:  Int J Legal Med       Date:  2016-11-25       Impact factor: 2.686

Review 7.  "Troponin elevation in coronary ischemia and necrosis".

Authors:  Stefan Agewall; Evangelos Giannitsis
Journal:  Curr Atheroscler Rep       Date:  2014-03       Impact factor: 5.113

8.  The never-ending story of cardiac biomarkers: A further step toward a very early detection of ischemic patients?

Authors:  Claudio Marcassa
Journal:  J Nucl Cardiol       Date:  2018-03-06       Impact factor: 5.952

9.  Fabrication of Anti-human Cardiac Troponin I Immunogold Nanorods for Sensing Acute Myocardial Damage.

Authors:  Zr Guo; Cr Gu; X Fan; Zp Bian; Hf Wu; D Yang; N Gu; Jn Zhang
Journal:  Nanoscale Res Lett       Date:  2009-08-21       Impact factor: 4.703

10.  Polymorphisms of the ICAM-1 exon 6 (E469K) are associated with differentiation of colorectal cancer.

Authors:  Qing-lei Wang; Bing-hui Li; Bin Liu; Ya-bin Liu; Yue-Ping Liu; Sui-Bing Miao; Yi Han; Jin-Kun Wen; Mei Han
Journal:  J Exp Clin Cancer Res       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.